Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?

被引：15
|
作者：
Ajonuma, Louis Chukwuemeka [1 ]
机构：
[1] St Marys Matern Hosp, Etiti, Imo State, Nigeria
来源：
MEDICAL HYPOTHESES | 2008年 / 70卷 / 06期
关键词：
D O I：
10.1016/j.mehy.2007.11.004
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Ovarian hyperstimulation syndrome (OHSS) remains one of the most life-threatening and potentially fatal complications of assisted reproduction treatments (ART), due to excessive stimulation of the ovaries by exogenously administrated gonadotropins. The pathogenesis of OHSS remains obscure and patient treatments are empirical. However, vascular endothelial growth factor (VEGF) has been suggested to be responsible for OHSS. The present hypothesis aims to discuss the possible role of epithelial ion channels particularly cystic fibrosis transmembrane conductance regulator (CFTR) involvement in the pathogenesis of OHSS. This may provide grounds for the development of a better treatment strategy to reduce the risk of OHSS and improve in vitro fertilization (IVF) outcome. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1174 / 1178
页数：5
相关论文
共 50 条
  • [41] VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF), A PARACRINE MEDIATOR OF TUMOR-GROWTH
    FERRARA, N
    LI, B
    KIM, J
    WINER, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S50 - S50
  • [42] Ovarian hyperstimulation syndrome: the role of vascular endothelial cadherin
    Villasante, A.
    Pacheco, A.
    Zuniga, A.
    Pellicer, A.
    Garcia-Velasco, J. A.
    HUMAN REPRODUCTION, 2003, 18 : 35 - 35
  • [43] Vascular endothelial growth factor (VEGF) emerging as a mediator of hereditary angioedema (HAE)
    Giavina-Bianchi, Pedro
    Aun, Marcelo Vivolo
    Kalil, Jorge
    WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (08):
  • [44] Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)—a retrospective case–control study
    Kazem Nouri
    Peter Haslinger
    Ladislaus Szabo
    Michael Sator
    Martin Schreiber
    Christian Schneeberger
    Detlef Pietrowski
    Journal of Ovarian Research, 7
  • [45] Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome
    Agrawal, R
    Tan, SL
    Wild, S
    Sladkevicius, P
    Engmann, L
    Payne, N
    Bekir, J
    Campbell, S
    Conway, G
    Jacobs, H
    FERTILITY AND STERILITY, 1999, 71 (02) : 287 - 293
  • [46] Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses
    Tanir, HM
    Ozalp, S
    Yalcin, OT
    Colak, O
    Akcay, A
    Senses, T
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (3-4) : 271 - 274
  • [47] Importance of vascular endothelial growth factor (VEGF) in ovarian physiology of mammals
    Araujo, Valdevane Rocha
    Graca Duarte, Ana Beatriz
    Bruno, Jamily Bezerra
    Pinho Lopes, Claudio Afonso
    de Figueiredo, Jose Ricardo
    ZYGOTE, 2013, 21 (03) : 295 - 304
  • [48] Intensive care treatment of ovarian hyperstimulation syndrome (OHSS)
    Sansone, Pasquale
    Audio, Caterina
    Pace, Maria Caterina
    Esposito, Raffaella
    Passavanti, Maria Beatrice
    Pota, Vincenzo
    Pace, Leonardo
    Pezzullo, Martina Gilda
    Bulletti, Carlo
    Palagiano, Antonio
    REPRODUCTIVE SCIENCE, 2011, 1221 : 109 - 118
  • [49] Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review
    Delvigne, A
    Rozenberg, S
    HUMAN REPRODUCTION UPDATE, 2002, 8 (06) : 559 - 577
  • [50] Ovarian Hyperstimulation Syndrome (OHSS) Presented as Massive Hydrothorax
    Saha, Pradip Kumar
    Goel, Poonarn
    Tandon, Rimpy
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (12) : 2996 - 2997
12345